| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.051 | 0.5 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.037 | 0.5 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.5 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | -0.035 | 0.5 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |